+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ocaliva"

Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • November 2024
  • 110 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Obeticholic Acid Market Report 2025 - Product Thumbnail Image

Obeticholic Acid Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market 2025-2033 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market 2025-2033

  • Report
  • March 2025
  • 142 Pages
  • Global
From
NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 130 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • January 2023
  • 130 Pages
  • Global
From
NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026) - Product Thumbnail Image

NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

  • Report
  • March 2021
  • 210 Pages
  • Global
From
OCALIVA Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

OCALIVA Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
UDCA Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

UDCA Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Primary Biliary Cholangitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 97 Pages
  • Global
From
Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 195 Pages
  • Global
From
Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2022
  • 239 Pages
  • Global
From
Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 136 Pages
  • Global
From
Bile Duct Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Bile Duct Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel

  • Report
  • April 2022
  • 178 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Ocaliva is a drug used to treat primary biliary cholangitis (PBC), a chronic liver disorder, and polycystic kidney disease (PKD), a genetic disorder that affects the kidneys. It is a small molecule inhibitor of the enzyme farnesoid X receptor (FXR), which is involved in the regulation of bile acid metabolism. Ocaliva is the only approved FXR agonist for the treatment of PBC and PKD. It is available in both oral and intravenous formulations. Ocaliva is marketed by Intercept Pharmaceuticals, a biopharmaceutical company based in the United States. Other companies in the market include Gilead Sciences, Merck, and Novartis. Show Less Read more